Skip to main content
Erschienen in: World Journal of Surgery 6/2014

01.06.2014

The Role of Adrenal Scintigraphy in the Diagnosis of Subclinical Cushing’s Syndrome and the Prediction of Post-surgical Hypoadrenalism

verfasst von: Maria Pia Ricciato, Vincenzo Di Donna, Germano Perotti, Alfredo Pontecorvi, Rocco Bellantone, Salvatore M. Corsello

Erschienen in: World Journal of Surgery | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Management of subclinical Cushing’s syndrome (SCS) remains controversial; it is not possible to predict which patients would benefit from adrenalectomy. In the present study we aimed to evaluate the role of adrenocortical scintigraphy (ACS) in the management of patients with SCS.

Methods

The medical records of 33 consecutive patients with adrenal “incidentaloma” and proven or suspected SCS who underwent 131I-19-iodocholesterol ACS between 2004 and 2010 were reviewed. Sixteen underwent laparoscopic adrenalectomy (surgical group—S-group) and 17 were medically managed (medical group—M-group). Follow-up evaluation was obtained by outpatient consultation.

Results

Overall 25 patients (15 in the S-group and 10 in the M-group) had concordant unilateral uptake at ACS (ACS+). In the S-group, the mean follow-up duration was 30.9 ± 16.1 months and, irrespective of the presence of hormonal diagnosis of SCS, in patients who were ACS+ adrenalectomy resulted in a significant increase in HDL cholesterol and decreases in body mass index, glycemia, and blood pressure (BP). One patient reduced antihypertensive medication and three others were able to discontinue it altogether. Prolonged postoperative hypoadrenalism (PH) occurred in 14 patients in the S-group. The overall accuracy in predicting PH was 93.7 % for ACS and 68.7 % for laboratory findings. In the M-group, the mean follow-up duration was 31.5 ± 26.3 months and no patient developed overt Cushing’s syndrome, although ACS+ patients experienced a worsening in glycemia and diastolic BP.

Conclusions

Adrenal scintigraphy seems the most accurate diagnostic test for SCS. It is able to predict the metabolic outcome and the occurrence of PH, identifying the patients who could benefit from adrenalectomy irrespective of hormonal diagnosis.
Literatur
1.
Zurück zum Zitat Reincke M (2000) Subclinical Cushing’s syndrome. Endocrinol Metab Clinic North Am 29:43–56CrossRef Reincke M (2000) Subclinical Cushing’s syndrome. Endocrinol Metab Clinic North Am 29:43–56CrossRef
2.
Zurück zum Zitat Terzolo M, Pia A, Reimondo G et al (2012) Subclinical Cushing’s syndrome: definition and management. Clin Endocrinol 76:12–18CrossRef Terzolo M, Pia A, Reimondo G et al (2012) Subclinical Cushing’s syndrome: definition and management. Clin Endocrinol 76:12–18CrossRef
3.
Zurück zum Zitat Barzon L, Sonino N, Fallo F et al (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273–285PubMedCrossRef Barzon L, Sonino N, Fallo F et al (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273–285PubMedCrossRef
4.
Zurück zum Zitat Ross NS (1994) Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 23:539–546PubMed Ross NS (1994) Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 23:539–546PubMed
5.
Zurück zum Zitat Barzon L, Fallo F, Sonino N (2002) Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 146:61–66PubMedCrossRef Barzon L, Fallo F, Sonino N (2002) Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 146:61–66PubMedCrossRef
6.
Zurück zum Zitat Barzon L, Scaroni C, Sonino N et al (1998) Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Enocrinol Metabol 83:55–62 Barzon L, Scaroni C, Sonino N et al (1998) Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Enocrinol Metabol 83:55–62
7.
Zurück zum Zitat Bourdeau I, D’Amour P, Hamet P et al (2001) Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing’s syndrome. J Clin Endocrinol Metabol 86:5534–5540 Bourdeau I, D’Amour P, Hamet P et al (2001) Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing’s syndrome. J Clin Endocrinol Metabol 86:5534–5540
8.
Zurück zum Zitat Christopoulos S, Bordeau I, Lacroix A (2005) Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Horm Res 64:119–131PubMedCrossRef Christopoulos S, Bordeau I, Lacroix A (2005) Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Horm Res 64:119–131PubMedCrossRef
9.
Zurück zum Zitat Boronat M, Moreno A, Ramon y et al (1997) Subclinical Cushing’s syndrome due to adrenal myelolipoma. Arch Pathol Lab Med 121:735–737PubMed Boronat M, Moreno A, Ramon y et al (1997) Subclinical Cushing’s syndrome due to adrenal myelolipoma. Arch Pathol Lab Med 121:735–737PubMed
10.
Zurück zum Zitat De Leo M, Cozzolino A, Colao A et al (2012) Subclinical Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 26:497–505PubMedCrossRef De Leo M, Cozzolino A, Colao A et al (2012) Subclinical Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 26:497–505PubMedCrossRef
11.
Zurück zum Zitat Di Dalmazi G, Vicennati V, Rinaldi E et al (2012) Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol 166:669–677PubMedCrossRef Di Dalmazi G, Vicennati V, Rinaldi E et al (2012) Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol 166:669–677PubMedCrossRef
12.
Zurück zum Zitat Abdelmannan D, Aron DC (2010) Adrenal incidentalomas and subclinical Cushing’s syndrome. Rev Endocr Metab Disord 11:135–140PubMedCrossRef Abdelmannan D, Aron DC (2010) Adrenal incidentalomas and subclinical Cushing’s syndrome. Rev Endocr Metab Disord 11:135–140PubMedCrossRef
13.
Zurück zum Zitat Palmieri S, Morelli V, Polledri E et al (2013) The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism. Eur J Endocrinol 168:289–296PubMedCrossRef Palmieri S, Morelli V, Polledri E et al (2013) The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism. Eur J Endocrinol 168:289–296PubMedCrossRef
14.
Zurück zum Zitat Grumbach MM, Biller BMK, Braunstein GD et al (2003) Management of clinically inapparent adrenal mass (incidentaloma). Ann Intern Med 138:424–429PubMedCrossRef Grumbach MM, Biller BMK, Braunstein GD et al (2003) Management of clinically inapparent adrenal mass (incidentaloma). Ann Intern Med 138:424–429PubMedCrossRef
15.
Zurück zum Zitat Zeiger MA, Thompson GB, Duh QY (2009) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15:1–20PubMedCrossRef Zeiger MA, Thompson GB, Duh QY (2009) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15:1–20PubMedCrossRef
16.
Zurück zum Zitat Morelli V, Palmieri S, Salcuni AS et al (2013) Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. Eur J Endocrinol 168:235–241PubMedCrossRef Morelli V, Palmieri S, Salcuni AS et al (2013) Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. Eur J Endocrinol 168:235–241PubMedCrossRef
17.
Zurück zum Zitat Eller-Vainicher C, Morelli V, Salcuni AS et al (2010) Accuracy of several parameters of hypothalamic-pituitary-adrenal axis in predicting before surgery the metabolic effects of the removal of adrenal incidentaloma. Eur J Endocrinol 163:925–935PubMedCrossRef Eller-Vainicher C, Morelli V, Salcuni AS et al (2010) Accuracy of several parameters of hypothalamic-pituitary-adrenal axis in predicting before surgery the metabolic effects of the removal of adrenal incidentaloma. Eur J Endocrinol 163:925–935PubMedCrossRef
18.
Zurück zum Zitat Chiodini I (2010) Diagnosis and treatment of subclinical hypercortisolism. J Clin Enocrinol Metabol 96:1223–1236CrossRef Chiodini I (2010) Diagnosis and treatment of subclinical hypercortisolism. J Clin Enocrinol Metabol 96:1223–1236CrossRef
19.
Zurück zum Zitat Akehi Y, Kawate H, Murase K et al (2013) Proposed diagnostic criteria for subclinical Cushing’s syndrome associated with adrenal incidentaloma. Endocr J 60:903–912PubMedCrossRef Akehi Y, Kawate H, Murase K et al (2013) Proposed diagnostic criteria for subclinical Cushing’s syndrome associated with adrenal incidentaloma. Endocr J 60:903–912PubMedCrossRef
20.
Zurück zum Zitat Perysinakis I, Marakaki C, Avlonitis S et al (2013) Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome. Surg Endosc 27:2145–2148PubMedCrossRef Perysinakis I, Marakaki C, Avlonitis S et al (2013) Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome. Surg Endosc 27:2145–2148PubMedCrossRef
21.
Zurück zum Zitat Maehana T, Tanaka T, Itoh N et al (2012) Clinical outcomes of surgical treatment and longitudinal non-surgical observation of patients with subclinical Cushing’s syndrome and nonfunctioning adrenocortical adenoma. Indian J Urol 28:179–183PubMedCentralPubMedCrossRef Maehana T, Tanaka T, Itoh N et al (2012) Clinical outcomes of surgical treatment and longitudinal non-surgical observation of patients with subclinical Cushing’s syndrome and nonfunctioning adrenocortical adenoma. Indian J Urol 28:179–183PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Iacobone M, Citton M, Viel G et al (2012) Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing’s syndrome. Surgery 152:991–997PubMedCrossRef Iacobone M, Citton M, Viel G et al (2012) Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing’s syndrome. Surgery 152:991–997PubMedCrossRef
23.
Zurück zum Zitat Bernini G, Moretti A, Iacconi P et al (2003) Anthropometric, hemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148:213–219PubMedCrossRef Bernini G, Moretti A, Iacconi P et al (2003) Anthropometric, hemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148:213–219PubMedCrossRef
24.
Zurück zum Zitat Sippel R, Chen H (2004) Subclinical Cushing’s syndrome in adrenal incidentalomas. Surg Clin North Am 84:875–885PubMedCrossRef Sippel R, Chen H (2004) Subclinical Cushing’s syndrome in adrenal incidentalomas. Surg Clin North Am 84:875–885PubMedCrossRef
25.
Zurück zum Zitat Erbil Y, Ademoğlu E, Ozbey N et al (2006) Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg 30:1665–1671PubMedCrossRef Erbil Y, Ademoğlu E, Ozbey N et al (2006) Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg 30:1665–1671PubMedCrossRef
26.
Zurück zum Zitat Mitchell C, Auchus R, Juneja K et al (2007) Subclinical Cushing’s syndrome is not so subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900–905PubMedCrossRef Mitchell C, Auchus R, Juneja K et al (2007) Subclinical Cushing’s syndrome is not so subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900–905PubMedCrossRef
27.
Zurück zum Zitat Tsuiki M, Tanabe A, Takagi S et al (2008) Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing’s syndrome. Endocr J 55:737–745PubMedCrossRef Tsuiki M, Tanabe A, Takagi S et al (2008) Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing’s syndrome. Endocr J 55:737–745PubMedCrossRef
28.
Zurück zum Zitat Kasperlik-Zaluska A, Otto M, Cichocki A et al (2008) 161 patients with adrenal incidentalomas: indications for surgery. Langen Arch Surg 393:121–126CrossRef Kasperlik-Zaluska A, Otto M, Cichocki A et al (2008) 161 patients with adrenal incidentalomas: indications for surgery. Langen Arch Surg 393:121–126CrossRef
29.
Zurück zum Zitat Mazzuco T, Bourdeau I, Lacroix A (2009) Adrenal incidentalomas and subclinical Cushing’s syndrome: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 16:203–210PubMed Mazzuco T, Bourdeau I, Lacroix A (2009) Adrenal incidentalomas and subclinical Cushing’s syndrome: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 16:203–210PubMed
30.
Zurück zum Zitat Guerrieri M, Compagnacci R, Patrizi A et al (2010) Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. Surg Endosc 24:2542–2546PubMedCrossRef Guerrieri M, Compagnacci R, Patrizi A et al (2010) Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. Surg Endosc 24:2542–2546PubMedCrossRef
31.
Zurück zum Zitat Mauclère-Denost S, Duron-Mertinaud S, Nunes ML et al (2009) Surgical excision of subclinical cortisol secreting incidentalomas: impact on blood pressure, BMI and glucose metabolism. Ann Endocrinol 70:211–217CrossRef Mauclère-Denost S, Duron-Mertinaud S, Nunes ML et al (2009) Surgical excision of subclinical cortisol secreting incidentalomas: impact on blood pressure, BMI and glucose metabolism. Ann Endocrinol 70:211–217CrossRef
32.
Zurück zum Zitat Toniato A, Merante-Boschin I, Opocher G et al (2009) Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 249:388–391PubMedCrossRef Toniato A, Merante-Boschin I, Opocher G et al (2009) Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 249:388–391PubMedCrossRef
33.
Zurück zum Zitat Chiodini I, Morelli V, Salcuni AS et al (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95:2645–2736 Chiodini I, Morelli V, Salcuni AS et al (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95:2645–2736
34.
Zurück zum Zitat Dominguez-Gaeda L, Diez L, Piedrola-Maroto G et al (1996) Scintigraphic diagnosis of subclinical Cushing’s syndrome in patients with adrenal incidentalomas. Nucl Med Commun 17:29–32CrossRef Dominguez-Gaeda L, Diez L, Piedrola-Maroto G et al (1996) Scintigraphic diagnosis of subclinical Cushing’s syndrome in patients with adrenal incidentalomas. Nucl Med Commun 17:29–32CrossRef
35.
Zurück zum Zitat Izaki H, Fukumori T, Takayashi M et al (2006) Indications for laparoscopic adrenalectomy for non-functional tumor with hypertension: usefulness of adrenocortical scintigraphy. Int J Urol 13:677–681PubMedCrossRef Izaki H, Fukumori T, Takayashi M et al (2006) Indications for laparoscopic adrenalectomy for non-functional tumor with hypertension: usefulness of adrenocortical scintigraphy. Int J Urol 13:677–681PubMedCrossRef
36.
Zurück zum Zitat Fagour C, Bardet S, Rohmer V et al (2009) Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study. Eur J Endocrinol 160:257–264PubMedCrossRef Fagour C, Bardet S, Rohmer V et al (2009) Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study. Eur J Endocrinol 160:257–264PubMedCrossRef
37.
Zurück zum Zitat Donadio F, Morelli V, Salcuni AS et al (2009) Role of adrenal scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J Endocrinol Invest 32:576–580PubMedCrossRef Donadio F, Morelli V, Salcuni AS et al (2009) Role of adrenal scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J Endocrinol Invest 32:576–580PubMedCrossRef
38.
Zurück zum Zitat Expert Panel on detection, evaluation, and treatment of High blood cholesterol in adults (Adults Treatment Panel III) (2002) Third report of the national cholesterol education program (NCEP): final report. Circulation 106:3143–3421 Expert Panel on detection, evaluation, and treatment of High blood cholesterol in adults (Adults Treatment Panel III) (2002) Third report of the national cholesterol education program (NCEP): final report. Circulation 106:3143–3421
40.
Zurück zum Zitat Shen WT, Lee J, Kebebew E et al (2006) Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg 141:771–774PubMedCrossRef Shen WT, Lee J, Kebebew E et al (2006) Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg 141:771–774PubMedCrossRef
41.
Zurück zum Zitat Feng C, Li HZ, Xiao H et al (2007) Subclinical Cushing’s syndrome: analysis of diagnosis and surgical effect. Zhonghua Wai Ke Za Zhi 45:1691–1693PubMed Feng C, Li HZ, Xiao H et al (2007) Subclinical Cushing’s syndrome: analysis of diagnosis and surgical effect. Zhonghua Wai Ke Za Zhi 45:1691–1693PubMed
42.
Zurück zum Zitat Eller-Vainicher C, Morelli V, Salcuni A et al (2010) Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol A 162:91–99CrossRef Eller-Vainicher C, Morelli V, Salcuni A et al (2010) Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol A 162:91–99CrossRef
Metadaten
Titel
The Role of Adrenal Scintigraphy in the Diagnosis of Subclinical Cushing’s Syndrome and the Prediction of Post-surgical Hypoadrenalism
verfasst von
Maria Pia Ricciato
Vincenzo Di Donna
Germano Perotti
Alfredo Pontecorvi
Rocco Bellantone
Salvatore M. Corsello
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 6/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2482-6

Weitere Artikel der Ausgabe 6/2014

World Journal of Surgery 6/2014 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.